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PENGKLONAN DAN EKSPRESI TERLEBIH DEOKSIRIBONUKLEASE (NucB) 
DARIPADA Bacillus licheniformis DALAM SISTEM EKSPRESI E. coli 
 
ABSTRAK 
 
Deoksiribonuklease NucB daripada Bacillus licheniformis ATCC 14580 dijangka 
berpotensi menguraikan biofilem mikrob iaitu struktur biologi yang boleh menyebabkan 
banyak komplikasi buruk dalam konteks industri dan kesihatan kerana ia mempunyai 94% 
persamaan dengan B. licheniformis strain EI- 34-6 yang dipencil dari laut dan telah 
menunjukkan keupayaan untuk menguraikan biofilem yang dibentuk oleh kedua-dua 
golongan bakteria Gram-positif dan Gram-negatif dengan cepat. Deoksiribonuklease NucB 
merupakan nuklease luar sel yang dihasilkan oleh gen NucB yang mempunyai 429 
pasangan asas nukleotida dengan saiz 15.332 kDa. Mekanisme tindakannya dalam 
penguraian biofilem dianggap berkaitan dengan pencernaan satu komponen penting dalam 
bahan polimer luar sel biofilem iaitu DNA luar sel yang berfungsi mengekalkan integriti 
struktur biofilem. Pencernaan DNA luar sel menyebabkan ketidakstabilan matriks bahan 
polimer luar sel biofilem dan seterusnya menguraikan biofilem secara lengkap. Selain itu, 
NucB daripada Bacillus dikatakan mempunyai potensi yang lebih tinggi berbanding dengan 
nuklease-nuklease lain termasuk DNase I dalam pencernaan DNA luar sel. Tujuan kajian 
ini dijalankan adalah untuk mengklon dan mengekspres NucB deoksiribonuklease dengan 
menggunakan plasmid pET dan sistem ekspresi protein E. coli. Protein rekombinan akan 
dilabel dengan tag asid amino 6× histidine di terminal karboksil bagi memudahkan 
pengesanan dan purifikasi. Konstruk rekombinan pada mulanya dibentuk dan kemudian 
dimasukkan dalam E. coli untuk mengekspres protein dengan menggunakan kedua-dua 
xii 
 
induksi konvensional dengan IPTG dan autoinduksi. Perbezaan tahap ekspresi antara 
sampel induksi dan tanpa induksi pada mulanya dinilai melalui kajian SDS PAGE. 
Seterusnya, penampilan protein rekombinan disahkan dengan analisis Western blot. 
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CLONING AND OVEREXPRESSION OF DEOXYRIBONUCLEASE (NucB) 
FROM Bacillus licheniformis IN E. coli EXPRESSION SYSTEM 
 
ABSTRACT 
 
NucB deoxyribonuclease of Bacillus licheniformis ATCC 14580 is expected to disperse the 
microbial biofilm which is a problematic biological structure notorious for causing 
numerous complications in a variety of industrial and healthcare context due to its 94% 
similarity with that of the marine-isolated B. licheniformis strain EI-34-6 in which the latter 
has demonstrated the ability to rapidly break up the biofilms formed by both Gram-positive 
and Gram-negative bacteria. It is an extracellular nuclease encoded by the 429 base pairs 
NucB gene and assuming the size of 15.332 kDa. Its mechanism of action in relation to 
biofilm dispersal is thought to be the digestion of one important component of the biofilm 
extracellular polymeric substances (EPS) responsible for the biofilm structural integrity 
namely the extracellular DNA (eDNA). Digestion of the eDNA causes loosening of the 
EPS matrix leading to total removal of the biofilm. Besides, the Bacillus NucB was claimed 
to have higher potency compared to other nucleases including DNase I in degrading the 
eDNA. This study focused to clone and overexpress the NucB deoxyribonuclease using the 
pET vector and E. coli expression system in which the recombinant protein will be tagged 
with the fusion partner, a 6× polyhistidine at the carboxyl terminal to facilitate detection 
and purification. The recombinant construct was first formed and subsequently transformed 
into the E.coli expression host for expression using both conventional IPTG induction and 
autoinduction. The difference in the expression level between the induced and the 
xiv 
 
uninduced samples was initially observed through SDS PAGE study. The final Western 
blot analysis showed the presence of the His-tagged target protein. 
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CHAPTER 1 
INTRODUCTION 
 
1.1     Literature review  
 
1.1.1     Nucleases  
Nucleases belong to the hydrolases enzymatic group capable of cleaving the phosphodiester 
bonds between the nucleotide subunits of nucleic acids (Ashok Kumar and Kannan, 2011). 
They are commonly found in prokaryotes and eukaryotes and are diverse based on their 
localization, structure, function and mode of action. Nucleases can be broadly categorised 
into sugar-specific nucleases and sugar non-specific nucleases according to the substrates 
they hydrolyze. Within sugar specific nucleases which cleave either DNA or RNA, there 
are deoxyribonucleases and ribonucleases. Deoxyribonucleases further branch into 
topoisomerases, recombinases, restriction endonucleases and damage-specific nucleases all 
of which are protein nucleases. For non-protein nucleases, there are ribozymes or RNA 
splicing enzymes (Mishra, 1995).  
 
Deoxyribonucleases and ribonucleases can be either endonucleases or exonucleases 
depending on the type of nucleolytic attack. Generally, endonucleases are enzymes that 
cleave DNA from within the molecule while exonucleases cleave at the ends of the 
molecule. Deoxyribonucleases are the enzymes that can break phosphodiester linkages of 
DNA (Sheikh and Rosseini, 2014) while ribonucleases are enzymes that break down RNA. 
Topoisomerases are enzymes that control the topology which is the winding of DNA at 
certain steps during DNA replication in prokaryotic and eukaryotic cells (Lodish et al., 
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2000). Recombinases are nucleases that promote dsDNA breaks repair and allow genetic 
recombination in the recombination hot-spots vicinity (Jockovich and Myers, 2001). 
Restriction endonucleases are enzymes that cleave DNA at specific recognition sites 
(Raghavendra and Rao, 2003) whilst damage-specific nucleases are nucleases that act on 
damaged DNA to play a central role in DNA repair. Sugar non-specific nucleases 
hydrolyze both DNA and RNA without showing definite base preferences and they are 
multifunctional enzymes that are distributed extensively and have functions in nutrition, 
DNA replication, recombination and repair (Rangarajan and Shankar, 2001). Ribozymes 
are RNAs with catalytic activity analogous to that of protein enzymes (Talini et al., 2011). 
 
Nucleases are evidenced to play crucial roles in range of cellular and genetic mechanisms. 
These include the regulation of processes such as DNA replication, repair, recombination 
and mutagenesis (Baker and Kornberg, 1992). Besides, nucleases are also found to be 
implicated in the control of gene expression by deciding the nature and turnover of gene 
transcripts. In addition, gene transposition and rearrangements also require the activity of 
nucleases (Mishra, 1995). The role in host defense against foreign nucleic acids to protect 
the integrity of host genomes is as well one of the salient features of nucleases (Hsia et al., 
2005).  
 
In both eukaryotes and prokaryotes, the various biological roles of nucleases and their 
applications have been elucidated to great extent (Mishra, 1995). While the functions of 
nucleases were extensively understood within a cell, which predominantly are related to 
DNA replication and repair, RNA maturation, restriction and molecular applications (Marti 
and Fleck, 2004), information on the diversity and importance of extracellular nucleases in 
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the natural environment is scarce. However, there were a number of different types of 
extracellular nucleases produced by assorted groups of microbial communities that have 
been identified in researches carried out previously (Rajarajan, 2013).  
 
1.1.1.1     Bacterial extracellular DNase  
Extracellular enzymes or exoenzymes are enzymes which are totally separated from the cell 
and found free in the surrounding medium yet the division is marginal between them and 
the cell wall or membrane-bound enzymes (Priest, 1977). Despite the fact that extracellular 
DNases are produced by numerous pathogenic bacteria, the advantage of enzymatic activity 
of extracellular DNases is not well understood (Sumby et al., 2005). It was assumed that 
DNase secretion allows DNA hydrolysis which in turn provides a growth advantage due to 
enlargement of the pool of available nucleotides (Fox and Holtman, 1968). Also, 
extracellular DNase activity was proposed to be involved in the propagation of bacteria. It 
has been hypothesized to be responsible for liquifying pus to disseminate and spread 
infecting bacteria (Sherry and Goeller, 1950).  
 
Furthermore, in a current study, extracellular DNases were claimed to play a part in 
degrading neutrophil extracellular traps which are composed of chromatin and granule 
proteins that can trap and kill bacteria extracellularly and therefore contribute to evasion of 
the innate immune response (Brinkmann et al., 2004). The exogenous addition of 
extracellular DNase was demonstrated to have significantly diminished the bactericidal 
activity of neutrophils directed against Shigella flexneri and Staphylococcus aureus 
(Brinkmann et al., 2004). Another discovery of the distinguished function of extracellular 
DNases is their ability to break up established biofilms and to prevent de novo formation of 
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biofilms of competitors (Nijland et al., 2010). The DNases can lead to reduction of biofilm 
and total bacterial biomass, decreased viability of bacteria and declined tolerance to 
antibiotics which could cause eradication of other competitive bacterial species (Tetz and 
Tetz, 2010).  
 
1.1.1.2     NucB DNase of Bacillus licheniformis ATCC 14580  
 
1.1.1.2.1     B. licheniformis ATCC 14580  
B. licheniformis is a Gram-positive bacterium, an endospore former that can be isolated 
worldwide from soils and plant materials (Sneath et al., 1986). It was suggested to be 
widely distributed in the environment in form of a saprophytic organism (Alexander, 1977). 
B. licheniformis is closely related to B. subtilis and was considered to belong to the B. 
subtilis group II along with other recognized species whose complete genome sequence has 
been resolved such as B. anthracis (Read et al., 2003), B. cereus (Rasko et al., 2004), B. 
thuringiensis, B. halodurans (Takami et al., 2000) and B. subtilis (Kunst et al., 1997). The 
genome features of B. licheniformis and comparison with other Bacillus species is shown in 
Table 1.1. 
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Table 1.1: Genome features of B. licheniformis and comparison with other Bacillus species.  
 
 
 
[Source: Rey et al., 2004] 
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It is an organism that has been studied in detailed second only to E. coli. B. licheniformis is 
a facultative anaerobe in contrast to majority of the bacilli which are mostly aerobic and 
this trait may allow it to tolerate and grow in additional wider ecological niches. There was 
no report that the organism is pathogenic for either animals or plants. It is widely used for 
producing exoenzymes in large-scale due to its capability of secreting large quantities of 
proteins of up to 20-25g/l (Schallmey et al., 2004). B. licheniformis and its extracellular 
products have abundant commercial and agricultural applications. Many industrial enzymes 
such as proteases, α-amylase, penicillinase, pentosanase, cycloglucosyltransferase, β-
mannanase and several pectinolytic enzymes have been manufactured using the species 
(Erickson, 1976). In addition to various specialty chemicals like citric acid, inosine, 
inosinic acid and poly-γ-glutamic acid, peptide antibiotics for example bacitracin and 
proticin are produced by specific strains of B. licheniformis (Pienta et al., 1989). Several 
isolates of B. licheniformis can also be employed to tone down fungal pathogens that attack 
the maize, grasses and vegetable crops (Neyra et al., 1996).  
 
According to (Rey et al., 2004), the genome of B. licheniformis strain ATCC 14580 has 
4,222,336 base pairs and comprises 4208 predicted protein-coding sequences. The overall 
average genomic guanosine and cytosine content is 46.2%. Besides, there were no plasmids 
identified during the genome analysis and agarose gel electrophoresis. The protein-coding 
sequences were stated to have occupied 87% of the genome. They have lengths ranging 
from 78bp to 10,767bp, with 873bp on average. The sequences are mainly oriented in the 
direction of replication on the chromosome in which 74.4% of the genes are on the leading 
strand while the remaining 25.6% reside on the lagging strand (Rey et al., 2004). 
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Based on the updated information in NCBI, B. licheniformis strain ATCC 14580 has the 
NCBI reference sequence number of NC_006270.3. Its genome is a circular chromosome 
with 4222597 base pairs and a total of 4332 genes. Besides, the number of true protein 
coding sequences is 4173. There are also 66 pseudogenes, 21 rRNAs and 72 tRNAs being 
reported (NCBI, 2014).  
 
Among the 4,208 predicted protein coding genes according to Rey et al. (2014), 3948 genes 
have high similarity to proteins in the non-redundant annotated protein sequence database, 
Protein Information Resource. 76% of the 3948 gene models contain Interpro motifs and 69% 
contain protein motifs found in the PFAM database of protein families. There were also 
1106 hypothetical proteins and 212 conserved hypothetical proteins in the B. licheniformis 
genome with hits in the Protein Information Resource database (Rey et al., 2004).  
 
The SignalP server which functions to predict the presence and location of signal peptide 
cleavage sites in protein sequences from diverse organisms has estimated that 689 of the 
4208 gene models in the B. licheniformis genome have signal peptides (Nielsen et al., 
1997). Signal peptides are short peptides present at the N-terminus of most of the newly 
synthesized proteins that are directed to proceed to the secretory pathway (Blobel and 
Dobberstein, 1975). Of the 689 genes, the TransMembrane prediction using Hidden 
Markov Models server (TMHMM) has predicted that 309 have no transmembrane domain 
(Krogh et al., 2001) and 134 are hypothetical or conserved hypothetical genes. Meanwhile, 
for the remaining 175 genes, at least 82 are expected to encode secreted proteins and 
enzymes after a manual examination. Additionally, B. licheniformis ATCC 14580genome 
was also proposed to encode 27 predicted extracellular proteins that are not found in the B. 
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subtilis. Being a saprophytic organism, B. licheniformis was also assumed to encode 
multitude of secreted enzymes involved in hydrolysis of polysaccharides, proteins, lipids 
and other nutrients (Rey et al., 2004).  
 
1.1.1.2.2     NucB DNase  
The NucB DNase from B. licheniformis ATCC 14580 is an extracellular DNase. The 
complete gene sequence has a total size of 429 base pairs as shown in Figure 1.1. It is a 
linear DNA sequence located in the bacterial chromosome from base 1976301 to base 
1976729 as shown in Figure 1.2. 
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  1 atgatcaaaa aatgggcggt tcatctgctg ttttccgcat tggtactgct  
    tgggctttcg  
 61 ggaggcgccg catattctcc tcagcatgcc gaaggtgctg caaggtatga  
    cgacatattg  
121 tattttccgg catcacgcta tcccgaaacc ggcgctcata tcagcgacgc  
    aatcaaagca  
181 gggcattcag atgtctgcac gattgaaaga tcgggagcgg ataagcgccg  
    ccaggaatca  
241 ctgaagggga ttccgactaa gccgggcttt gaccgtgacg aatggccgat  
    ggccatgtgt  
301 gaagaagggg gcaaaggagc gtctgtcaga tatgtcagct catcggataa  
    ccgcggagcc  
361 ggctcctggg tcgggaacag gctgagcggt ttcgccgacg ggacgagaat  
    tttgtttatc  
421 gttcaataa  
 
[Source: NCBI, 2013]  
 
Figure 1.1: B. licheniformis ATCC 14580 chromosomal NucB gene sequence. 
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[Source: NCBI, 2014]  
 
Figure 1.2: B. licheniformis ATCC 14580 chromosomal NucB gene location. 
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The nucleotide blast (blastn) performed using the B. licheniformis ATCC 14580 
chromosomal NucB gene sequence as entry query sequence and nucleotide collection (nr/nt) 
as the search database produced the BLAST search result as shown in Figure 1.3. The blast 
output showed that the query sequence has similarity with several sequences.  
 
The NucB gene sequence of B. licheniformis ATCC 14580 (Accession no: CP000002.3) 
and that of B. licheniformis DSM 13(Accession no: AE017333.1) have 100% identity. The 
B. licheniformis strain EI-34-6 has only the established NucB gene sequence in the 
database but not the whole genome sequence. Its NucB gene complete coding sequence 
(Accession no: HQ112343.1) is identical to that of B. licheniformis ATCC 14580 strain by 
94%. The same goes to B. licheniformis 9945A (Accession no: CP005965.1) in which the 
identity to the query sequence is 94%. For Paenibacillus graminis strain DSM 15220 
(Accession no: CP009287.1), only 20% of the query sequence is aligned with which gives 
rise to 85% identity (NCBI, 2014).  
 
In term of protein, the NucB DNase is composed of 142 amino acids as shown in Figure 1.4 
with the GenPept, NCBI accession number of Q65J43 (NCBI, 2006). Based on the 
information from Uniprot, the protein has the molecular mass of 15.332 kDa and is a 
member of the deoxyribonuclease NucA/NucB family which has the deoxyribonuclease 
NucA/NucB domain and acts as a deoxyribonuclease (UniProt, 2004). 
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[Source: NCBI, 2014]  
 
Figure 1.3: Distribution of 5 blast hits on B. licheniformis ATCC 14580 chromosomal 
NucB gene. 
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    1 mikkwavhll fsalvllgls ggaayspqha egaaryddil yfpasrypet gahisdaika  
  61 ghsdvctier sgadkrrqes lkgiptkpgf drdewpmamc eeggkgasvr yvsssdnrga  
121 gswvgnrlsg fadgtrilfi vq  
 
[Source: NCBI, 2006]  
 
Figure 1.4: B. licheniformis ATCC 14580 NucB DNase amino acid sequence. 
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According to the BioCyc Database Collection, NucB is a sporulation-specific extracellular 
nuclease (BioCyc, 2014). Besides, based on the STRING (Search Tool for the Retrieval of 
Interacting Genes/Proteins) known and predicted protein-protein interaction database, the 
NucB DNase is estimated to have four predicted functional partners with the network 
display illustrated in Figure 1.5. The functional partners are thyA (thymidylate synthase) 
which has 279 amino acids that provides the sole de novo source of deoxythymidine 
monophosphate for DNA biosynthesis, YckB protein with 291 amino acids which is 
predicted to be the ABC transporter substrate-binding protein, YckK protein with 268 
amino acids which has transporter activity and finally the hypothetical protein BL03601 
which has 151 amino acids (STRING, 2014).  
 
The blastp result shows that NucB DNase has significant alignments with a number of 
proteins in which the distribution of 100 blast hits on the query sequence has identity 
ranges from 100% to 55%. The protein with 100% identity to NucB is a sporulation protein 
from the Bacillus without specification of the species and with NCBI accession number of 
WP_003182220 while the protein having 55% identity to NucB is the sporulation protein 
from Paenibacillus sp. A9 with accession number of WP_026136223.1 (NCBI, 2015).  
 
PSIPRED (Psi-blast based secondary structure prediction) is a highly accurate protein 
structure prediction server that provides the predicted secondary structure of proteins 
(McGuffin et al., 2000). The predicted secondary structure of NucB composed of alpha 
helix, beta strand and random coil along with the legend is shown in Figure 1.6. The 
iterative threading assembly refinement (I-TASSER) is a bioinformatics approach for 
automated protein structure and function prediction starting from the amino acid sequence 
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to structure to function prediction (Roy et al., 2010). The predicted 3-dimensional model of 
NucB DNase is displayed in Figure 1.7. 
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[Source: STRING, 2014]  
 
Figure 1.5: B. licheniformis ATCC 14580 NucB DNase predicted functional partners 
network. 
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[Source: UCL Bioinformatics Group, 2015]  
 
Figure 1.6: Predicted secondary structure of NucB DNase. 
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[Source: I-TASSER, 2015]  
 
Figure 1.7: Predicted 3-dimensional model of NucB DNase. 
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1.1.1.2.3     Application of NucB DNase  
On the whole, there are two life forms of bacteria during growth and proliferation. The 
bacteria can either exist as single, independent cells known as the planktonic form or in 
form of sessile aggregates called biofilm (Bjarnsholt, 2013). Biofilm is a mixture of 
microbial cells and extracellular polymeric substances made up of polysaccharides, proteins, 
lipids and extracellular DNA (eDNA) (Flemming et al., 2007). Extensive studies on acute 
infections caused by pathogenic bacteria have been carried out for more than a decade. 
However, in recent study, it was found that a new class of chronic infections caused by 
bacteria growing in the biofilm form contributes to bacterial pathogenesis. High death rate 
was observed as a result of biofilm infections for example pneumonia in patients suffering 
from cystic fibrosis, chronic wounds, chronic otitis media and implant- and catheter-
associated infections which affect millions of people in the developed world each year 
(Bjarnsholt, 2013). Microbial biofilms hence are noted to have great importance for public 
health due to their association with certain infectious diseases and a variety of device-
related infections (Donlan, 2002).  
 
The formation of biofilms facilitates unicellular organisms to assume a momentary 
multicellular lifestyle which is important for survival in adverse environments. Such 
transition to biofilm structure from the planktonic form is triggered by environmental 
changes and engrosses multiple regulatory networks that in turn convey signals to initiate 
change in gene expression that finally mediate spatial and temporal reorganization of the 
bacterial cell (Monds and O’Toole, 2009). Consequence of such cellular restructuring is the 
alteration of the expression of surface molecules, nutrient consumption, virulence factors 
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and the bacteria is conferred with multitude of properties crucial for their survival in hostile 
conditions (Klebensberger et al., 2009).  
 
Acute infections were mostly attributable to planktonic bacteria which are usually easily 
treated with antibiotics even though accurate and fast diagnosis plays essential parts in 
successful treatment. On the other hand, the infection caused by biofilm bacteria frequently 
becomes refractory and will develop into a chronic state. The imperative feature of 
infections caused by bacteria in form of biofilm is the high resistance to antibiotics and 
majority of conventional antimicrobial agents as well as the exceptional ability to evade the 
host defences (Bjarnsholt, 2013).  
 
In the current treatment strategy against bacterial infections, use of antibiotics is still the 
main or favored option. There are two ways conventional antibiotics work against bacteria 
which are either bacteriostatic that is stopping the bacterial cells from growing or 
bactericidal that is the killing of the bacterial cells (Kostakioti et al., 2013). Despite 
antibiotics have been the crucial resolution in eradicating bacterial pathogens over the years, 
there are multitudes of evidence revealing the damage they render on the host microbiota 
and thereby facilitating the flourish of opportunistic pathogens which in turn develop 
higher resistance to antibiotics (Ubeda et al., 2010).  
 
Due to the extracellular matrix of biofilm that poses diffusion limitations, increased 
transmission of resistance markers within the biofilm community, high metal ion 
concentration and low pH that inactivate antibiotics and the presence of metabolically 
inactive persistent cells surviving the treatment, biofilm bacteria become intractable to 
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antibiotic treatments (Lewis, 2008). Biofilm bacteria thus acquire up to 1000-fold more 
resistance to antibiotics compared to planktonic cells by the abovementioned features 
(Høiby et al., 2010). As a consequence, higher effectiveness treatments to overcome 
biofilm are indispensable. Figure 1.8 shows several strategies developed lately to destroy 
the bacteria or target certain biofilm developmental stages to prevent biofilm formation 
(Kostakioti et al., 2013).  
 
NucB deoxyribonuclease from B. licheniformis strain EI-34-6 was shown to be able to 
rapidly disintegrate the biofilms formed by both Gram-positive and Gram-negative bacteria 
(Nijland et al., 2010). The robust biofilms formed by bacteria involved in chronic 
rhinosinusitis could also be diminished through NucB treatment in vitro (Shields et al., 
2013). NucB deoxyribonuclease has an effective mechanism of action in dispersing 
preformed biofilms and was suggested to be released as a significant enzyme to degrade the 
biofilm (Shakir et al., 2012). The nuclease was predicted to digest the eDNA and cause 
loosening of the EPS matrix which finally leads to total removal of the biofilms. Besides, 
NucB was claimed to be more superior in degrading eDNA compared to other nucleases 
including DNase I (Rajarajan et al., 2013). As NucB of B. licheniformis ATCC 14580 is as 
well an extracellular deoxyribonuclease and share 94% similarity with the NucB 
deoxyribonuclease from B. licheniformis strain EI-34-6, it is expected to have the ability to 
digest the eDNA of biofilm to cause dispersal. 
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[Source: Kostakioti et al., 2013]  
 
Figure 1.8: Stages in biofilm development and strategies to disrupt biofilm formation at 
specific stages. 
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1.1.2     Gene cloning  
Gene cloning is the production of multiple copies of a single gene using recombinant DNA 
technology which is an umbrella term involving the transfer of genetic information from 
one organism to another (Glick et al., 2010). Recombinant DNA technology has an overall 
aim of identifying, isolating, manipulating and re-expressing genes from a given host 
(Lewin, 1990). The practical goals of such cut-and-paste technology include developing a 
fundamental understanding of the function and regulation of known gene products, 
identifying new genes whose proteins have been isolated as in reverse genetics, rectifying 
endogenous genetic defects, expressing foreign genes in disease-susceptible hosts and 
manufacturing a protein product in large quantities for particular application (Carroll, 1993). 
The objectives can be met by a variety of methods yet a recombinant DNA experiment 
usually follows a certain typical steps (Glick et al., 2010).  
 
In order to clone a DNA fragment, the recombinant DNA molecule must be created and 
copied many times using two essentially different DNAs namely the vector and the insert 
(Krebs et al., 2013). The DNA of interest is first isolated from donor organism. There are 
various sources of the targeted DNA depending on the end purpose which can be either 
DNA fragments representing a specific gene or part of a gene or sequences of the entire 
genome of an organism isolated in form of genomic DNA, complementary DNA, 
polymerase chain reaction products or chemically synthesized oligonucleotides (Allison, 
2009). Both targeted DNA and small autonomously replicating DNA molecules such as 
bacterial plasmids are treated with same restriction enzymes to produce compatible DNA 
ends. The plasmids act as carriers or vectors for the targeted DNA. A range of vector 
systems apart from plasmids such as bacteriophage lambda, cosmid, bacteriophage P1, 
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bacterial artificial chromosome, P1-bacteriophage-derived artificial chromosome, yeast 
artificial chromosome and mammalian artificial chromosome each requiring specific host 
cells are available depending on the size of insert (Glick et al., 2010). The insert and 
plasmid vector are mixed and treated with enzyme DNA ligase to ligate them, forming the 
vector-insert DNA construct or recombinant DNA. The recombinant plasmids are added to 
competent bacterial cells in which under the right conditions, some of the bacteria will take 
in the plasmid through a process known as transformation. Bacterial cells are plated and 
allowed to grow into colonies on antibiotic selection plates. The recombinant plasmid is 
copied as the bacterial cells replicate. Subsequently, individual transformed cells with 
single recombinant vector will divide into a colony comprising millions of cells, all 
carrying the same recombinant vector. The recombinant vector can be extracted and 
analysis of the cloned DNA fragment can be performed. The recombinant vector with 
correct cloned DNA can be reintroduced into other host cells to carry out specific functions 
and manipulations (Griffiths et al., 2000). The target gene can also be expressed through 
transcription and translation in the host cells to produce targeted proteins when required 
(Shivanand and Noopur, 2010).  
 
1.1.3     Protein expression  
Proteins are extensively used in research, medicine and industry yet the extraction of 
proteins from their natural sources can be complicated and costly (Ma et al., 2003). As the 
applications requiring high amounts of good-quality proteins hit the market in increasing 
trend, efficient recombinant protein production strategies are gaining escalating importance. 
Despite hundreds of proteins are produced at commercial scale, the production of 
recombinant proteins remains a challenge in many circumstances. Furthermore, it will be 
